Suven Life Sciences Value Analysis March 2026
Comments Off on Suven Life Sciences Value Analysis March 2026
Suven Life Sciences — Investment Analysis Report Equity Research | NSE: SUVEN · BSE: 530239 · Indian Pharmaceuticals / CNS Biotech March 2026 Deep Dive · Investment Analysis Report Suven Life SciencesLimited India’s only…
Laurus Labs — DCF analysis March 2026
Comments Off on Laurus Labs — DCF analysis March 2026
Laurus Labs — Investment Research Report Zumedha Investment Research NSE: LAURUSLABS | BSE: 540222 29 March 2026 | Sector: Pharmaceuticals / CDMO LAURUSLABS CMP ₹984 52W Range ₹517 – ₹1,141 Mkt Cap ₹53,400 Cr P/E (TTM) ~65x…